Cellular and molecular mechanism of lead neurotoxicity;Mecanismos celulares y moleculares de la neurotoxicidad por plomo

Salud Mental

Volumn 28, Issue 2, 2005, Pages 48-58

  Garza, Aníbal ^a   Chávez, Hortencia ^a   Vega, Rosario ^a   Soto, Enrique ^a  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

Calcium channels; Calcium binding sites; Ionic channels; Lead; Neurotoxicity; Neurotransmission

Indexed keywords

AMINO ACID; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM BINDING PROTEIN; CALCIUM CHANNEL; CALMODULIN; CARRIER PROTEIN; CELL ADHESION MOLECULE; DIVALENT CATION; DNA BINDING PROTEIN; ION CHANNEL; LEAD; PROTEIN KINASE C; SYNAPTOTAGMIN;

BINDING SITE; BRAIN DISEASE; CALCIUM TRANSPORT; CELL FUNCTION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; ELECTRICITY; ENVIRONMENTAL EXPOSURE; HUMAN; LEAD POISONING; MEMBRANE FILTER; METALLURGY; MINING; MOLECULAR INTERACTION; NERVE EXCITABILITY; NEUROTOXICITY; NEUROTRANSMISSION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PATHOGENESIS; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN TARGETING; REVIEW;

EID: 20444470385     PISSN: 01853325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. 2+ promotes lipid oxidation and alterations in membrane physical properties. Toxicology, 132(1):19-32, 1999.
2. AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY (ATSDR). Toxicological profile for lead. U.S. Department of Health and Human Services, Public Health Service, Atlanta, 1999.
3. BALLATORI N: Transport of toxic metals by molecular mimicry. Environ Health Perspect, 110(Supl 5):689-694, 2002.
4. BELLINGER DC: Lead. Pediatrics, 113(4 Supl):1016-1022, 2004.
5. BERG J, LIPPARD S: Principles of Bioinorganic Chemistry. University Science Books. California, 1994.
6. BOUTON CM, FRELIN LP, FORDE CE, ARNOLD GODWIN H, PEVSNER J: Synaptotagmin I is a molecular target for lead. J Neurochem, 76(6):1724-1735, 2001.
7. BRANDEN C, TOOZE J: Introduction to Protein Structure (Segunda edición). Garland Publishing, Nueva York, 1999.
8. BRESSLER J, KIM KA, CHAKRABORTI T, GOLDSTEIN G: Molecular mechanisms of lead neurotoxicity. Neurochem Res, 24(4):595-600, 1999.
9. 2+ channel. J Gen Physiol, 116(4):569-586, 2000.
10. FUJIWARA Y: Cell biological study on abnormal proteoglycan synthesis in vascular cells exposed to heavy metals. J Health Sci, 50(3):197-204, 2004.
11. GHOSH A, GREENBERG ME: Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science, 268(5208):239-247, 1995.
12. GIMENO S, GERRITSEN A, BOWMER T, KOMEN H: Feminization of male carp. Nature, 384(6606):221-222, 1996.
13. GODWIN HA: The biological chemistry of lead. Curr Opin Chem Biol, 5(2):223-227, 2001.
14. HANAS JS, RODGERS JS, BANTLE JA, CHENG YG: Lead inhibition of DNA-binding mechanism of Cys(2) His(2) zinc finger proteins. Mol Pharmacol, 56(5):982-988, 1999.
15. HASHEMZADEH-GARGARI H, GUILARTE TR: Divalent cations modulate N-methyl-D-aspartate receptor function at the glycine site. J Pharmacol Exp Ther, 290(3):1356-1362, 1999.
16. HE L, POBLENZ AT, MEDRANO CJ, FOX DA: Lead and calcium produce rod photoreceptor cell apoptosis by opening the mitochondrial permeability transition pore. J Biol Chem, 275(16):12175-12184, 2000.
17. HECHTENBERG S, BEYERSMANN D: Inhibition of sarcoplasmic reticulum Ca(2+)-ATPase activity by cadmium, lead and mercury. Enzyme, 45(3):109-115, 1991.
18. KATZ AK, GLUSKER JP, BEEBE SA, BOCK CW: Calcium ion coordination: a comparison with that of beryllium, magnesium and zinc. J Am Chem Soc, 118:5752-5763, 1996.
19. KLAASSEN C: Heavy metals and heavy-metal antagonists. En: Hardman J, Iimbird L, Gilman A (eds). The Pharmacological Basis of Therapeutics (decimal edición). McGraw Hill, pp. 1851-1875, Nueva York, 2001.
20. LEINDERS T, VAN KLEEF RG, VIJVERBERG HP: Divalent cations activate small- SK and large-conductance BK channels in mouse neuroblastoma cells: selective activation of SK channels by cadmium. Pflugers Arch, 422(3):217-222, 1992.
21. LEWIT-BENTLEY A, RETY S: EF-hand calcium-binding proteins. Curr Opin Struct Biol, 10(6):637-643, 2000.
22. LIDSKY TI, SCHNEIDER JS: Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain, 126(Pt 1):5-19, 2003.
23. 2+ on delayed-rectifier potassium channels in acutely isolated hippocampal neurons. J Neurophysiol, 78(5):2649-2654, 1997.
24. MANALIS RS, COOPER GP, POMEROY SL: Effects of lead on neuromuscular transmission in the frog. Brain Res, 294(1):95-109, 1984.
25. MAZZOLINI M, TRAVERSO S, MARCHETTI C: Multiple pathways of Pb(2+) permeation in rat cerebellar granule neurones. J Neurochem, 79(2):407-416, 2001.
26. MCNEILL DR, NARAYANA A, WONG HK, WILSON DM 3rd: Inhibition of Ape1 nuclease activity by lead, iron, and cadmium. Environ Health Perspect, 112(7):799-804, 2004.
27. MIELKE HW: Lead in the Inner Cities. American Scientist, 87(1):62-73, 1999.
28. 2+ of alpha7-containing nicotinic acetylcholine receptors in hippocampal neurons. Brain Res, 873(1):112-123, 2000.
29. NAGATA K, HUANG CS, SONG JH, NARAHASHI T: Lead modulation of the neuronal nicotinic acetylcholine receptor in PC12 cells. Brain Res, 754(1-2):21-27, 1997.
30. NELSON MR, CHAZIN WJ: Calmodulin as a calcium sensor. En: Van Eldik L, Watterson D (eds). Calmodulin and Signal Transduction. Academic Press, 17-64, San Diego, 1998.
31. OPLER MG, BROWN AS, GRAZIANO J, DESAI M, ZHENG W, SCHAEFER C, FACTOR-LITVAK P, SUSSER ES: Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. Environ Health Perspect, 112(5):548-552, 2004.
32. 2+ channels transiently expressed in human embryonic kidney 293 cells. Mol Pharmacol, 62(6):1418-1430, 2002.
33. PROZIALECK WC, GRUNWALD GB, DEY PM, REUHL KR, PARRISH AR: Cadherins and NCAM as potential targets in metal toxicity. Toxicol Appl Pharmacol, 182(3):255-265, 2002.
34. QIAN Y, TIFFANY-CASTIGLIONI E: Lead-induced endoplasmic reticulum (ER) stress responses in the nervous system. Neurochem Res, 28(1):153-162, 2003.
35. 2+-binding domain. J Biol Chem, 273(26):15879-15882, 1998.
36. SAIMI Y, KUNG C: Calmodulin as an ion channel subunit. Ann Rev Physiol, 64:289-311, 2002.
37. SALFORD LG, BRUN AE, EBERHARDT JL, MALMGREN L, PERSSON BR: Nerve cell damage in mammalian brain after exposure to microwaves from GSM mobile phones. Environ Health Perspect, 111(7):881-883, 2003.
38. SATHER WA, MCCLESKEY EW: Permeation and selectivity in calcium channels. Annu Rev Physiol, 65:133-159, 2003.
39. SHIMONI-LIVNY L, GLUSKER JP, BOCK CW: Lone pair functionality in divalent lead compounds. Inorg Chem, 37:1853-1867, 1998.
40. SUDHOF TC: Synaptotagmins: why so many?. J Biol Chem, 277(10):7629-7632, 2002.
41. 2+ and protein kinase C and its role in norepinephrine release from bovine adrenal chromaffin cells. J Neurochem, 64(6):2667-2673, 1995.
42. TONG S, VON SCHIRNDING YE, PRAPAMONTOL T: Environmental lead exposure: a public health problem of global dimensions. Bull World Health Organ, 78(9):1068-1077, 2000.
43. UJIHARA H, SASA M, BAN T. Selective blockade of P-type calcium channels by lead in cultured hippocampal neurons. Jpn J Pharmacol, 67(3):267-269, 1995.
44. VETTER SW, LECLERC E: Novel aspects of calmodulin target recognition and activation. Eur J Biochem, 270(3):404-414, 2003.
45. VILLEDA-HERNANDEZ J, BARROSO-MOGUEL R, MENDEZ-ARMENTA M, NAVA-RUIZ C, HUERTA-ROMERO R, RIOS C: Enhanced brain regional lipid peroxidation in developing rats exposed to low level lead acetate. Brain Res Bull, 55(2):247-251, 2001.
46. WAKEFIELD J: The lead effect? Environ Health Perspect, 110(10):A574-A580, 2002.
47. 2+-calmodulin. Acta Crystallogr D Biol Crystallog, 59(Pt 10):1782-1792, 2003.
48. YOKEL RA: Brain uptake, retention, and efflux of aluminum and manganese. Environ Health Perspect, 110 (Supl 5):699-704, 2002.